Rx-to-OTC switches can revolutionize the lineup of modern healthcare, significantly broadening consumer accessibility for the most valuable and proven therapeutics. Properly-crafted switches empower consumers to become increasingly more responsible for managing their own health. With two high profile successful switches in the past year, now is the time to re-evaluate key lessons and understand their influence on the market. DGE invites you to its 3rd Rx-to-OTC Switch conference on February 26-27 in Philadelphia! The industry’s only event to specifically focus on the challenges associated with this niche topic! Don’t miss the opportunity to hear from industry experts about case studies on the latest successful switches, regulatory challenges concerning ACNU, digital advancements, marketing strategies, and much more!
- Rx-to-OTC Switch/Rx Access
- Legal & Regulatory
- Brand Management/Strategy
- Product Management
- Brand Marketing
- Global Marketing
- Legal Affairs
- Medical/Scientific Affairs
- Consumer Healthcare Product
- Consumer Marketing
- Clinical Development
- Clinical Trial
- Drug Safety
- Regulatory Affairs
- Research and Development
- Business Strategy
- Packaging & Labeling
- Drug Delivery Technology
- Product Development
- Portfolio Strategy
- Project Management
- General Counsel
- Clinical Research
- Commercialization
Stay up to date on the latest announcements